Bruker Analyst Ratings
Bruker Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 3.72% | JP Morgan | $70 → $65 | Maintains | Neutral |
| 05/05/2023 | 51.59% | Citigroup | $90 → $95 | Maintains | Buy |
| 04/19/2023 | 11.7% | Goldman Sachs | $63 → $70 | Maintains | Sell |
| 04/18/2023 | 11.7% | Goldman Sachs | $63 → $70 | Maintains | Sell |
| 02/10/2023 | 43.61% | Citigroup | $80 → $90 | Maintains | Buy |
| 10/21/2022 | 11.7% | UBS | → $70 | Initiates Coverage On | → Buy |
| 08/22/2022 | 27.65% | Citigroup | $70 → $80 | Upgrades | Neutral → Buy |
| 05/05/2022 | 38.82% | SVB Leerink | $85 → $87 | Maintains | Outperform |
| 04/13/2022 | -4.26% | Goldman Sachs | $73 → $60 | Maintains | Sell |
| 02/14/2022 | 35.63% | SVB Leerink | $84 → $85 | Maintains | Outperform |
| 11/02/2021 | 43.61% | Wells Fargo | $85 → $90 | Maintains | Equal-Weight |
| 09/09/2021 | 59.57% | SVB Leerink | $90 → $100 | Maintains | Outperform |
| 08/03/2021 | 35.63% | Wells Fargo | $70 → $85 | Maintains | Equal-Weight |
| 06/18/2021 | 35.63% | SVB Leerink | $80 → $85 | Maintains | Outperform |
| 06/15/2021 | — | Cleveland Research | Upgrades | Neutral → Buy | |
| 02/05/2021 | -12.24% | Wells Fargo | → $55 | Downgrades | Overweight → Equal-Weight |
| 01/27/2021 | 11.7% | SVB Leerink | $50 → $70 | Maintains | Outperform |
| 11/16/2020 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 08/04/2020 | -25% | Citigroup | $38 → $47 | Maintains | Neutral |
| 08/04/2020 | -20.22% | SVB Leerink | $45 → $50 | Maintains | Outperform |
| 07/20/2020 | -21.81% | B of A Securities | $43 → $49 | Maintains | Buy |
| 05/07/2020 | -39.36% | Citigroup | $40 → $38 | Maintains | Neutral |
| 05/07/2020 | -32.98% | Wells Fargo | $50 → $42 | Maintains | Overweight |
| 04/28/2020 | -34.58% | UBS | $53 → $41 | Maintains | Neutral |
| 04/02/2020 | -44.15% | Stifel | $52 → $35 | Maintains | Hold |
| 04/01/2020 | — | Needham | Downgrades | Strong Buy → Hold | |
| 03/26/2020 | -23.41% | Barclays | $52 → $48 | Upgrades | Equal-Weight → Overweight |
| 03/20/2020 | -36.17% | Citigroup | $52 → $40 | Maintains | Neutral |
| 02/19/2020 | 0.53% | Needham | $62 → $63 | Maintains | Strong Buy |
| 01/08/2020 | -4.26% | Wells Fargo | → $60 | Initiates Coverage On | → Overweight |
| 01/07/2020 | -17.03% | Citigroup | → $52 | Initiates Coverage On | → Buy |
| 11/15/2019 | -15.43% | Stifel | → $53 | Initiates Coverage On | → Hold |
| 09/26/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 07/15/2019 | -23.41% | Goldman Sachs | $32 → $48 | Upgrades | Sell → Neutral |
| 05/03/2019 | — | SVB Leerink | Upgrades | Market Perform → Outperform | |
| 04/12/2019 | — | Deutsche Bank | Upgrades | → Buy | |
| 01/03/2019 | -37.77% | Needham | → $39 | Initiates Coverage On | → Strong Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/17/2023 | 3.72% | 摩根大通 | $70→$65 | 維護 | 中性 |
| 05/05/2023 | 51.59% | 花旗集團 | $90→$95 | 維護 | 買 |
| 04/19/2023 | 11.7% | 高盛 | $63→$70 | 維護 | 賣 |
| 04/18/2023 | 11.7% | 高盛 | $63→$70 | 維護 | 賣 |
| 02/10/2023 | 43.61% | 花旗集團 | $80→$90 | 維護 | 買 |
| 2022年10月21日 | 11.7% | 瑞銀集團 | →$70 | 開始承保 | →購買 |
| 2022/08/22 | 27.65% | 花旗集團 | $70→$80 | 升級 | 中性→購買 |
| 05/05/2022 | 38.82% | SVB Leerink | $85→$87 | 維護 | 跑贏大盤 |
| 04/13/2022 | -4.26% | 高盛 | $73→$60 | 維護 | 賣 |
| 02/14/2022 | 35.63% | SVB Leerink | $84→$85 | 維護 | 跑贏大盤 |
| 11/02/2021 | 43.61% | 富國銀行 | $85→$90 | 維護 | 等重 |
| 09/09/2021 | 59.57% | SVB Leerink | $90→$100 | 維護 | 跑贏大盤 |
| 08/03/2021 | 35.63% | 富國銀行 | $70→$85 | 維護 | 等重 |
| 06/18/2021 | 35.63% | SVB Leerink | $80→$85 | 維護 | 跑贏大盤 |
| 2021/06/15 | - | 克利夫蘭研究公司 | 升級 | 中性→購買 | |
| 02/05/2021 | -12.24% | 富國銀行 | →$55 | 評級下調 | 超重→等重 |
| 2021/01/27 | 11.7% | SVB Leerink | $50→$70 | 維護 | 跑贏大盤 |
| 11/16/2020 | - | 沃爾夫研究 | 升級 | 表現不佳的→對等設備 | |
| 08/04/2020 | -25% | 花旗集團 | $38→$47 | 維護 | 中性 |
| 08/04/2020 | -20.22% | SVB Leerink | $45→$50 | 維護 | 跑贏大盤 |
| 07/20/2020 | -21.81% | B of A證券 | $43→$49 | 維護 | 買 |
| 05/07/2020 | -39.36% | 花旗集團 | $40→$38 | 維護 | 中性 |
| 05/07/2020 | -32.98% | 富國銀行 | $50→$42 | 維護 | 超重 |
| 04/28/2020 | -34.58% | 瑞銀集團 | $53→$41 | 維護 | 中性 |
| 04/02/2020 | -44.15% | Stifel | $52→$35 | 維護 | 保持 |
| 04/01/2020 | - | 李約瑟 | 評級下調 | 強力買入→Hold | |
| 03/26/2020 | -23.41% | 巴克萊 | $52→$48 | 升級 | 等重→超重 |
| 03/20/2020 | -36.17% | 花旗集團 | $52→$40 | 維護 | 中性 |
| 02/19/2020 | 0.53% | 李約瑟 | $62→$63 | 維護 | 強勢購買 |
| 1/08/2020 | -4.26% | 富國銀行 | →$60 | 開始承保 | →超重 |
| 1/07/2020 | -17.03% | 花旗集團 | →$52 | 開始承保 | →購買 |
| 2019年11月15日 | -15.43% | Stifel | →$53 | 開始承保 | →保留 |
| 2019年09月26日 | - | B of A證券 | 升級 | 中性→購買 | |
| 2019年07月15日 | -23.41% | 高盛 | $32→$48 | 升級 | 賣出→中性 |
| 2019年05月03日 | - | SVB Leerink | 升級 | 市場表現優於→ | |
| 2019年4月12日 | - | 德意志銀行 | 升級 | →購買 | |
| 2019年03月01日 | -37.77% | 李約瑟 | →$39 | 開始承保 | →強勢購買 |
What is the target price for Bruker (BRKR)?
布魯克(Bruker)的目標價是多少？
The latest price target for Bruker (NASDAQ: BRKR) was reported by JP Morgan on October 17, 2023. The analyst firm set a price target for $65.00 expecting BRKR to rise to within 12 months (a possible 3.72% upside). 6 analyst firms have reported ratings in the last year.
摩根大通於2023年10月17日報道了布魯克(納斯達克代碼：BRKR)的最新目標價。這家分析公司將目標價定為65.00美元，預計BRKR將在12個月內上漲(可能上漲3.72%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Bruker (BRKR)?
布魯克(BRKR)最近的分析師評級是多少？
The latest analyst rating for Bruker (NASDAQ: BRKR) was provided by JP Morgan, and Bruker maintained their neutral rating.
納斯達克(Sequoia Capital：BRKR)的最新分析師評級由摩根大通提供，布魯克維持中性評級。
When is the next analyst rating going to be posted or updated for Bruker (BRKR)?
布魯克(Bruker)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公開財務報表，與布魯克的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。布魯克的上一次評級是在2023年10月17日提交的，所以你應該預計下一次評級將在2024年10月17日左右的某個時候公佈。
Is the Analyst Rating Bruker (BRKR) correct?
分析師對布魯克(BRKR)的評級正確嗎？
While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $70.00 to $65.00. The current price Bruker (BRKR) is trading at is $62.67, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的布魯克(BRKR)評級維持不變，目標價在70.00美元至65.00美元之間。布魯克目前的交易價格為62.67美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。